[go: up one dir, main page]

FI974170A7 - B-adrenergisiä agonisteja - Google Patents

B-adrenergisiä agonisteja Download PDF

Info

Publication number
FI974170A7
FI974170A7 FI974170A FI974170A FI974170A7 FI 974170 A7 FI974170 A7 FI 974170A7 FI 974170 A FI974170 A FI 974170A FI 974170 A FI974170 A FI 974170A FI 974170 A7 FI974170 A7 FI 974170A7
Authority
FI
Finland
Prior art keywords
adrenergic agonists
adrenergic
agonists
Prior art date
Application number
FI974170A
Other languages
English (en)
Swedish (sv)
Other versions
FI974170A0 (fi
FI974170L (fi
Inventor
Robert Lee Dow
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI974170A0 publication Critical patent/FI974170A0/fi
Publication of FI974170A7 publication Critical patent/FI974170A7/fi
Publication of FI974170L publication Critical patent/FI974170L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Pyridine Compounds (AREA)
FI974170A 1995-05-10 1995-05-10 B-adrenergisiä agonisteja FI974170L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002220538A CA2220538A1 (en) 1995-05-10 1995-05-10 .beta.-adrenergic agonists
PCT/IB1995/000342 WO1996035670A1 (en) 1995-05-10 1995-05-10 β-ADRENERGIC AGONISTS

Publications (3)

Publication Number Publication Date
FI974170A0 FI974170A0 (fi) 1997-11-07
FI974170A7 true FI974170A7 (fi) 1997-11-07
FI974170L FI974170L (fi) 1997-11-07

Family

ID=25679804

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974170A FI974170L (fi) 1995-05-10 1995-05-10 B-adrenergisiä agonisteja

Country Status (6)

Country Link
EP (1) EP0828712A1 (fi)
JP (1) JPH11504648A (fi)
CN (1) CN1144801A (fi)
CA (1) CA2220538A1 (fi)
FI (1) FI974170L (fi)
WO (1) WO1996035670A1 (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981562A (en) * 1996-01-30 1999-11-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EA199900375A1 (ru) 1996-11-14 1999-12-29 Пфайзер Инк. Способ получения замещенных пиридинов
US6001856A (en) * 1997-06-13 1999-12-14 Pfizer Inc. β-adrenergic agonists to reduce a wasting condition
EP0997458A4 (en) * 1997-07-03 2003-03-05 Asahi Chemical Ind NOVEL TRICYCLIC COMPOUNDS HAVING SATUROUS CORES AND MEDICINAL COMPOSITIONS CONTAINING THEM
EP0920864A1 (en) * 1997-12-03 1999-06-09 Pfizer Products Inc. Combination therapy including a specific beta-3 agonist and an anorectic agent
US6090942A (en) * 1998-10-15 2000-07-18 Pfizer Inc. Process and intermediates for a β3 -adrenergic receptor agonist
US6861444B2 (en) * 2000-04-28 2005-03-01 Asahi Kasei Pharma Corporation Bicyclic compounds
DE60228990D1 (de) 2001-10-25 2008-10-30 Asahi Kasei Pharma Corp Bicyclische verbindung
JP2007509896A (ja) * 2003-11-03 2007-04-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング β−3−アドレノセプターアゴニスト及びαアンタゴニスト及び/又は5−αレダクターゼインヒビターを含有する医薬組成物
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
AU2009325091A1 (en) 2008-05-23 2010-06-17 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein inhibitor
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
KR20110050733A (ko) 2008-10-09 2011-05-16 아사히 가세이 파마 가부시키가이샤 인다졸 유도체
CA2740772A1 (en) 2008-10-09 2010-04-15 Asahi Kasei Pharma Corporation Indazole compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358455A (en) * 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
EP0105053B1 (en) * 1982-10-01 1988-01-20 Merck & Co. Inc. Aralkylaminoethanol heterocyclic compounds
GB8703007D0 (en) * 1987-02-10 1987-03-18 Glaxo Group Ltd Chemical compounds
NZ226991A (en) * 1987-11-27 1992-03-26 Merck & Co Inc Alpha-heterocyclically-substituted ethanolamines and use as animal growth promotors
US5019578A (en) * 1987-11-27 1991-05-28 Merck & Co., Inc. β-adrenergic agonists
EP0677043A1 (en) * 1992-12-29 1995-10-18 Smithkline Beecham Corporation Platelet aggregation inhibiting compounds
US5767133A (en) * 1993-06-14 1998-06-16 Pfizer Inc. Secondary amines as antidiabetic and antiobesity agents

Also Published As

Publication number Publication date
EP0828712A1 (en) 1998-03-18
FI974170A0 (fi) 1997-11-07
WO1996035670A1 (en) 1996-11-14
CN1144801A (zh) 1997-03-12
CA2220538A1 (en) 1996-11-14
JPH11504648A (ja) 1999-04-27
FI974170L (fi) 1997-11-07

Similar Documents

Publication Publication Date Title
FI974172A7 (fi) B-adrenergisiä agonisteja
EP0858444A4 (en) Cyclopentyl tachykinin receptor antagonists
DE69635315D1 (de) Kodeverteilvielfachzugriffskommunikationssystem
DE69636741D1 (de) Bleichkatalysatorteilchen
DE69623069D1 (de) Fahrzeugodometerkorrektursystem
DE69728300D1 (de) Spiralfluidummaschine
DE69636562D1 (de) Führungskathetereinführanordnung
DE69626325D1 (de) Einlegesohle
DE69620081D1 (de) Doppeltradwindkraftturbine
DE69633882D1 (de) Spreizspektrumübertragungsgerät
FI974170A0 (fi) B-adrenergisiä agonisteja
DE69603282D1 (de) Fluorrinierte polyisolyanate
FI950046A0 (fi) Radiosystem foer traodloes abonnentanslutning
DE69619217D1 (de) Viscositätsheizung
DE69627148D1 (de) Ringbusdatenübertragungssystem
DE69630477D1 (de) Breitbandsignalkodierer
DE69608465D1 (de) Persaüre
DK0725062T3 (da) 4-Mercapto-benzoylguanidin-derivater
DE69628432D1 (de) Förderband
ATE240972T1 (de) Cyclopeptolide
EP0794600A4 (en) Laser oscillator
DE69633762D1 (de) Blitzgerät
DE59610604D1 (de) Läuterbottich
BR9611733A (pt) Fluorobutenoiloxiacetamidas
KR970009914U (ko) 외등이 설치된 정자